INTRODUCTION 4 1
Exemplified by the discovery of cyclin proteins (Evans et al., 1983) , identifying biomolecules 4 2 whose abundance changes in the cell cycle has been a critical objective of cell cycle studies for 4 3 decades. Recognizing such molecular landmarks in the cell cycle is a valuable, and often 4 4 necessary, step for deciphering how and why cell cycle pathways are integrated. 4 5
Over the last twenty years, cell cycle-dependent changes in mRNA levels during the cell 4 6 cycle of S. cerevisiae have been comprehensively defined not only from several arrest-and-4 7 release synchronization approaches (Cho et al., 1998; Spellman et al., 1998;  One type of extract was analyzed for each class of the following biomolecules: RNA, primary 1 4 5 metabolites, biogenic amines, and lipids (see Materials and Methods and Table S1 ). For 1 4 6 proteomic analysis, we used soluble protein extracts (designated as 'sol' in the datasets, see 1 4 7 Table S1 ) and material from the same extract that was recovered in an insoluble pellet 1 4 8 1 cycle the levels of a TAP-tagged version of Thi7p from a commercially available strain collection 2 9 2 (Ghaemmaghami et al., 2003) , expressed from its endogenous chromosomal location. Thi7p 2 9 3 showed the smallest difference (slightly over 2-fold) in abundance during the cell cycle from our 2 9 4 mass spectrometry experiments and could provide a good measure to validate our results. Early 2 9 5 G1 cells carrying the THI7-TAP allele (the only available THI gene in the TAP-tagged strain 2 9 6 collection encoding any of the proteins shown in Figure 5A ) were obtained by elutriation and the 2 9 7 levels of the corresponding proteins were evaluated by immunoblotting at regular intervals, as 2 9 8 the cultures progressed in the cell cycle ( Figure 5B ). We confirmed by immunoblotting that the 2 9 9 abundance of Thi7p was elevated late in the cell cycle (see Figure 5B ; compared to the levels of 3 0 0 the control protein Pgk1p). These results are consistent with the notion that there might be a 3 0 1 coordinate, mitotic upregulation of thiamine biosynthesis enzymes. 3 0 2
Next, we asked if any TDP-dependent enzymes also change in abundance in the cell 3 0 3 cycle and if strains lacking these proteins have cell cycle-related phenotypes. TDP is a cofactor 3 0 4 for several enzymes, including transketolase (Tkl1,2p), α -ketoglutarate dehydrogenase (Kgd1p), 3 0 5 E1 subunit of pyruvate dehydrogenase (Pda1p), pyruvate decarboxylase (Pdc1,5,6p), and 3 0 6 phenylpyruvate decarboxylase (Aro10p). Only the levels of Tkl2p, Pdc5p, and Aro10p appeared 3 0 7 to be elevated late in the cell cycle ( Figure 5C ), at the same time as the levels of thiamine 3 0 8 biosynthesis enzymes were also raised ( Figure 5A ). 3 0 9
Cell size phenotypes are often used as a proxy for disrupted cell cycle progression with 3 1 0 an increased cell size phenotype typically accompanying mitotic defects. Of all deletion strains 3 1 1 lacking a protein that requires TDP as a cofactor, only the loss of Tkl2p increased cell size 3 1 2 significantly ( Figure 5D ). We found that both birth size and the mean size of tkl2Δ cells were 3 1 3 larger ( Figure 5D ). Note that the tkl2Δ deletion strain was not in the panels that were examined 3 1 4 in genome-wide screens of cell size mutants (Jorgensen et al., 2002; Zhang et al., 2002) . The 3 1 5 mitotic upregulation in the levels of thiamine biosynthesis enzymes ( Figure 5A ) and Tkl2p itself 3 1 6 ( Figure 5C ) are suggestive of possible mitotic roles for Tkl2p, which might depend on the 3 1 7 available TDP pools in the cell. In the Discussion, we speculate on such putative roles, based 3 1 8 on the published reports. 3 1 9 3 2 0
Cell cycle-dependent changes in metabolites and lipids 3 2 1
From the same elutriated pools we used to measure RNAs and proteins (see Figure 1 ), we also 3 2 2 measured metabolites and lipids. The assays were performed at the West Coast Metabolomics 3 2 3
Center at UC Davis, an NIH RCMRC (Regional Comprehensive Metabolomics Resource Core). 3 2 4
Each class of metabolites was measured with distinct mass spectrometry-based assays (see 3 2 5
Materials and Methods). From these assays, thousands of compounds were detected, but most 3 2 6 could not be assigned confidently to known metabolites, and they were not considered further. 3 2 7
Instead, we focused on the 406 primary metabolites, biogenic amines, and complex lipids that 3 2 8
were identified across the cell size series. As with our analysis of RNAs and proteins, we used 3 2 9
ANOVA (see Table S1 and Figure 6 ) to identify compounds whose levels change in the cell 3 3 0 cycle. Previous reports showed that storage carbohydrates are mobilized at the G1/S transition 3 3 1 (Ewald et al., 2016; Zhao et al., 2016) . Consistent with these studies, we also found that 3 3 2 trehalose levels rise in G1 to their highest levels when cell size reaches 50 fL, but drop 3 3 3 significantly at the G1/S transition ( Figure 6 ). By far, however, the class of metabolites that 3 3 4 changed the most in abundance in the cell cycle was complex lipids, which peaked late in the 3 3 5 cell cycle ( Figure 6 ). These included phospholipids (phosphatidyl-inositol (PI), -ethanolamine 3 3 6 (PE), -serine (PS)) and triglycerides ( Figure 6 ). The higher triglyceride levels are also consistent 3 3 7 with the elevated levels of neutral lipid droplets late in the G2/M phase, as reported previously 3 3 8 (Blank et al., 2017) . Overall, the coordinate increase in the levels of ergosterol biosynthesis 3 3 9 enzymes we identified from the proteomic analysis ( Figure 3A ) and the increase in lipids ( Figure  3 4 0 6), strongly suggest that lipid metabolism is significantly upregulated late in the cell cycle. In the 3 4 1
Discussion, we will expand on the significance of these results. 3 4 2 DISCUSSION 3 4 3
The sample-matched datasets for RNAs, proteins, metabolites, and lipids we generated from 3 4 4 budding yeast cells progressing synchronously in the cell cycle provide a comprehensive view 3 4 5 of these biomolecules in dividing cells. We discuss our findings in the context of the relation 3 4 6 between the transcriptome and the proteome and the integration of metabolite and lipid 3 4 7 measurements with other 'omic' datasets. 3 4 8
In yeast, the latest meta-analyses from all available studies estimated that between 37% 3 4 9 and 56% of the variance in protein abundance is explained by mRNA abundance (Ho et al., 3 5 0 2018). These estimates are within the range of previous ones from multiple species (Vogel and 3 5 1 Marcotte, 2012) . Based on the absolute quantification of protein and mRNA abundances 3 5 2 (Lahtvee et al., 2017) , the overall correlation between mRNA and protein abundances was also 3 5 3 in that range (R 2 =0.45, based on Pearson's correlation coefficient). The level of correlation 3 5 4 between the transcriptome and the proteome we observed appears to be somewhat higher 3 5 5 (ρ=0.52-0.63, based on Spearman's coefficient), probably because our experiments were done 3 5 6 from synchronous cells, and because cell cycle transitions are associated with transcriptional 3 5 7
waves (Spellman et al., 1998) . A critical role for transcription in shaping the proteome takes 3 5 8 place as cells transition in different environments, and during such transitions changes in protein 3 5 9 levels were much more highly correlated with the changes in mRNA levels (R 2 >0.9) (Lahtvee et 3 6 0 al., 2017). Hence, the relatively high correlation we observed between the transcriptome and the 3 6 1 proteome in the cell cycle is not surprising, and it is probably an underestimate, since some 3 6 2 extremely unstable cell cycle regulators whose levels rise as a result of transcription (e.g., 3 6 3 cyclins, see Figure 1C ), were absent from our proteomic datasets because of their low 3 6 4 abundance. 3 6 5
Despite the correlation between the transcriptome and the proteome we discussed 3 6 6 above, there were clear groups of transcripts and proteins whose abundance was incongruent. 3 6 7
Ribosomal biosynthesis, reflected on the levels of individual ribosomal proteins or assembled 3 6 8 ribosomes, was not periodic at the proteomic level ( Figures 4 and S5) , despite a large G1 3 6 9 transcriptional wave of RNAs involved in this process ( Figure 2 ). We noted that a similar 3 7 0 phenomenon was recently reported for the integrated stress response, a well-characterized 3 7 1 transcriptional response in yeast involving ~900 transcripts (Gasch et al., 2000) , which was not 3 7 2 seen at all at the protein level (Ho et al., 2018) . The observation that the ribosome content of the 3 7 3 cell is constant in the cell cycle ( Figure 4 ) suggests that changes in translational efficiency of 3 7 4 some mRNAs described previously (Blank et al., 2017) are likely due to transcript-specific 3 7 5 mechanisms, rather than global changes in the steady-state ribosome content (Lodish, 1974 ). 3 7 6
The mitotic peak in the levels of TDP biosynthesis enzymes was surprising ( Figure 5 ). 3 7 7
The physiological significance of such a change in the levels of these enzymes is unclear. 3 7 8
Through some uncharacterized roles, the TDP-dependent transketolase activity is necessary for 3 7 9 meiotic progression in mouse oocytes (Kim et al., 2012) . In bacteria, transketolase participates 3 8 0 in chromosomal topology, and E.coli cells lacking transketolase are UV-sensitive (Hardy and 3 8 1 Cozzarelli, 2005) . However, we found that yeast tkl2Δ cells are not sensitive to UV or other 3 8 2 DNA-damaging agents (not shown). Overall, despite the intriguing observations that late in the 3 8 3 cell cycle, levels of the TDP-dependent Tkl2p transketolase were higher ( Figure 5C ) and loss of 3 8 4
Tkl2p increased cell size ( Figure 5D ), the molecular mechanism connecting these observations 3 8 5 remains to be determined. 3 8 6
The coordinate upregulation of ergosterol biosynthetic enzymes late in the yeast cell 3 8 7 cycle (Figure 3) , not evident at the RNA level ( Figure 2 ), was unexpected. To our knowledge, 3 8 8 there is no prior report of such a response. It should be noted that the lack of cell cycle-3 8 9 dependent changes at the levels of mRNAs encoding the enzymes of ergosterol biosynthetis 3 9 0 was seen not only in our dataset, but also in the other datasets aggregated in the Cyclebase 3.0 3 9 1 database for yeast and other organisms (Santos et al., 2015) . Of the enzymes we show in 3 9 Figure 3A , only ERG3 had a rank score of 624, while all others were not periodic (scores >800) 3 9 3 (Santos et al., 2015) . Note that we also found ERG3 mRNA levels to significantly change in the 3 9 4 cell cycle (see File4/Sheet: 'rnas_anova_heatmap'). 3 9 5
The mitotic rise in the levels of sterol biosynthetic enzymes is significant in the context of 3 9 6 our metabolite measurements, showing that lipid levels (especially phospholipids and 3 9 7 triglycerides) increased at the same time ( Figure 6 ). Our observations are consistent with 3 9 8 several other reports linking lipid metabolism with cell cycle progression and mitotic entry in 3 9 9
yeast (Anastasia et al., 2012; McCusker and Kellogg, 2012) . Levels of triglycerides increase in 4 0 0 wild-type cells synchronized in mitosis (Blank et al., 2017) , storage of triglycerides in lipid 4 0 1 droplets is thought to fuel mitotic exit (Yang et al., 2016) , and lipid-exchange proteins integrate 4 0 2 lipid signaling with cell-cycle progression (Huang et al., 2018) . Note that there have not been 4 0 3 analytical measurements of distinct lipids in the cell cycle in yeast. The data we show here are 4 0 4 not only consistent with, but also significantly expand the prior studies mentioned above. It is 4 0 5 also important to stress that an increase in lipids late in the cell cycle cannot simply be due to a 4 0 6 need for cell surface material. We had shown previously that increased lipogenesis does not 4 0 7 increase cell size (Blank et al., 2017) . Hence, the increase in the abundance of lipids likely 4 0 8 reflects changes in the composition of membranes or other more specialized, cell cycle-4 0 9 dependent process, not necessarily a simplistic need for more cell surface building blocks. 4 1 0
One also needs to consider the dramatic changes in cellular morphology. Especially 4 1 1 during mitosis, when the cell adopts the characteristic hourglass structure. The lipid content 4 1 2 must accommodate dynamic changes in membrane curvature. For example, during cytokinesis, 4 1 3 it is thought that lipids that confer negative curvature must be deposited on the outer leaflet of 4 1 4 the bilayer (Furse and Shearman, 2018). In yeast and human cells, inhibition of de novo fatty 4 1 5 acid biosynthesis arrests cells in mitosis (Hasslacher et al., 1993; Schneiter et al., 1996 ; Al-Feel 4 1 6 et al., 2003; Scaglia et al., 2014) . In human cells, cholesterol synthesis may affect multiple 4 1 7 points in the cell cycle. In an earlier report, inhibition of cholesterol synthesis arrested human 4 1 8 cells in mitosis (Suarez et al., 2002) , while in a later report the cells arrested in G1 (Singh et al., 4 1 9 2013). Cholesterol's role in mitosis appears to be complex, not only affecting the distribution of 4 2 0 phospholipids in the plasma membrane but also governing the formation of a vesicular network 4 2 1 at the midbody during cytokinesis (Kettle et al., 2015) . Interestingly, ergosterol may have a cell 4 2 2 cycle regulatory role in yeast, distinct from its bulk, structural role in membrane integrity (Dahl et 4 2 3 al., 1987), but that role remains unclear (Gaber et al., 1989) . Lastly, our results argue for post-4 2 4 transcriptional mechanisms leading to mitotic upregulation of sterol biosynthesis. As to how the 4 2 5 differential abundance of the ergosterol biosynthetic enzymes might come about, we note that 4 2 6 all the enzymes we show in Figure 3A , including Erg3p, have been shown to be 4 2 7 ubiquitinylated (Peng et al., 2003; Swaney et al., 2013) , raising the possibility of regulated 4 2 8 proteolysis. 4 2 9
Overall, our data underscore the value of having metabolite measurements along with 4 3 0 other 'omic' datasets, to strengthen the efforts of identifying physiologically relevant cellular 4 3 1 responses. In future work, employing targeted metabolic profiling and flux analysis in the cell 4 3 2 cycle will increase our understanding of how the transcriptome and proteome shape dynamic 4 3 3 changes in metabolism and how resources are allocated during cell division. 4 3 4 ACKNOWLEDGEMENTS: This work was supported by NIH grants R01GM123139 to M.P. and 4 3 5 grants from the NIH (R01 HD085901, R01 DK110520, R35 GM122480) and Welch Foundation 4 3 6 (F-1515) to E.M.M., with additional mass spectrometry research support from the Army 4 3 7
Research Laboratory (Cooperative Agreement # W911NF-17-2-0091). We also acknowledge 4 3 8 the support from the NCRR shared instrumentation grant 1S10 OD016281 (Buck Institute) and 4 3 9 from NIH grant 1U24DK097154 (UC Davis "West Coast Metabolomics Center"). All the strains used in this study are shown in the Key Resources Table, above. Unless noted 4 6 6 otherwise, the cells were cultivated in the standard, rich, undefined medium YPD (1% w / v yeast 4 6 7 extract, 2% w / v peptone, 2% w / v dextrose), at 30 °C (Kaiser et al., 1994) . 4 6 8 4 6 9 Elutriation 4 7 0
To collect enough cells for the downstream measurements of RNA, proteins, and metabolites, 4 7 1 we followed the same strategy we described previously (Blank et al., 2017) . Briefly, elutriated 4 7 2 wild type, G1 cells (diploid BY4743 background) were allowed to progress in the cell cycle until 4 7 3 they reached the desired cell size. At that point, they were quenched (with 100 µg/ml 4 7 4 cycloheximide and 0.1% sodium azide) and frozen away, and later pooled with cells of similar 4 7 5 size ( Figure 1A) . Overall, we had to collect 101 individual samples, to generate the 24 pools 4 7 6 shown in Figure 1A The methods to measure DNA content and the cell size (birth or mean size) of asynchronous 4 8 3 cultures and estimate the critical size of asynchronous cultures, have been described in detail 4 8 4 previously (Guo et al., 2004; Truong et al., 2013; Soma et al., 2014; Maitra et al., 2019) . We used ~1E+09 cells from each of the 24 pools of the cell size series (see Figure 1 ) to prepare 4 8 8 extracts for LC-MS/MS. For each sample, the cells were resuspended in 0.75 ml of lysis solution 4 8 9
(10 mM Tris pH 7.8, 10 mM NaCl). Glass beads were added to the top of liquid level, the 4 9 0 samples were placed in a Mini Beadbeater (Biospec), and the cells broken by 'bead-beating' 4 9 1 twice at the maximum speed for 90 s each time, placed on ice for 60 s between. The extract 4 9 2 from each sample was collected by punching a hole with a 21-gauge syringe needle at the 4 9 3 bottom of the tube. Lastly, the soluble material from the lysates were clarified by centrifugation 4 9 4 at 14,000 g at 4 °C, for 10 m. Insoluble pellets were resuspended in 500 μ l of lysis buffer and 4 9 5 both clarified supernatants and pellets were stored at -80 °C until processing for mass 4 9 6 spectrometry. 4 9 7
For mass spectral analysis, clarified extracts were thawed and protease inhibitors 4 9 8 immediately added. 50 μ l of each supernatant sample was mixed with 50 µl trifluoroethanol 4 9 9
(TFE) and reduced with 5mM tris(2-carboxyethyl)phosphine (TCEP) at 56 °C for 45 m, cooled 5 0 0
for 5 m at room temperature, and alkylated with 25 mM iodoacetamide in the dark, at room 5 0 1 temperature for 30 m. Samples were diluted 10-fold with digestion buffer (50 mM Tris pH 8.0, 2 5 0 2 mM calcium chloride), digested with trypsin (added at 1:50 ratio) at 37 °C for 5 h. Digestion was 5 0 3 stopped with 100 µl of 10% formic acid and sample volumes were reduced to 100-250 μ l in a 5 0 4
SpeedVac. Following filtration with an Amicon® Ultra-15 Centrifugal Filter Unit the peptides 5 0 5
were desalted using C18 Spin Tips, according to the manufacturer's instructions. The volume of 5 0 6 the samples was then reduced to 5-10 μ l in a SpeedVac. Lastly, the samples were resuspended 5 0 7 in 100 μ l of a 95% water, 5% acetonitrile, 0.1% formic acid solution, and subjected to LC-5 0 8 MS/MS analysis. 5 0 9
The insoluble pellets from the same extracts described above were processed based on 5 1 0 a method reported previously (Lin et al., 2013) . The pellets were resuspended in 50 μ l of 2% w / v 5 1 1 sodium dodecyl sulfate (SDS), 50 mM ammonium carbonate and heated at 95 °C for 10 m. 5 1 2
Following clarification each supernatant was transferred to a fresh tube, mixed with six volumes 5 1 3 of cold acetone (-20 °C) , and incubated at 4 °C for 4 h to form a precipitate. Precipitate was 5 1 4 recovered by centrifugation at 13,000 g for 15 m, the supernatant carefully removed by 5 1 5 aspiration, and the pellets washed twice with 0.4 ml of cold acetone. After each wash the 5 1 6 samples were centrifuged at 14,000 g for 1 m and the supernatant carefully aspirated. Pellets 5 1 7
were solubilized in 500 μ l of 1% w/v sodium deoxycholate, 50 mM ammonium carbonate with 5 1 8 two rounds of sonication (10 m each) in a water bath sonicator with 5 m on ice in between. 50 µl 5 1 9 of each sample was reduced and alkylated with TCEP and iodocateamide as described above. 5 2 0
Unreacted iodoacetamide was quenched with 12 mM dithiothreitol (DTT). The samples were 5 2 1 brought to 80 µl with digestion buffer and digested with trypsin (added at 1:50 ratio) at 37 °C for 5 2 2 5 h. Digestion was stopped with 1% formic acid and samples were centrifuged at 14,000 g for 5 2 3 10 m to pellet the precipitated sodium deoxycholate. Peptides were desalted with C18 Spin 5 2 4
Tips, and resuspended for LC-MS/MS as described above. 5 2 5
